20/20 Biolabs, Inc. Common Stock (AIDX)vsGE HealthCare Technologies Inc. (GEHC)
AIDX
20/20 Biolabs, Inc. Common Stock
$0.61
-7.75%
HEALTHCARE · Cap: $6.97M
GEHC
GE HealthCare Technologies Inc.
$64.86
+1.35%
HEALTHCARE · Cap: $29.51B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 1137158% more annual revenue ($20.98B vs $1.84M). GEHC leads profitability with a 9.1% profit margin vs -279.1%. GEHC earns a higher WallStSmart Score of 57/100 (C).
AIDX
Avoid21
out of 100
Grade: F
GEHC
Buy57
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -354.6% — below average capital efficiency
Expensive relative to growth rate
Weak financial health signals
Earnings declined 30.9%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AIDX
The strongest argument for AIDX centers on Debt/Equity, Price/Book.
Bull Case : GEHC
The strongest argument for GEHC centers on P/E Ratio, Price/Book.
Bear Case : AIDX
The primary concerns for AIDX are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
AIDX profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
GEHC carries more volatility with a beta of 0.86 — expect wider price swings.
GEHC is growing revenue faster at 7.4% — sustainability is the question.
GEHC generates stronger free cash flow (112M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (57/100 vs 21/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
20/20 Biolabs, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
20/20 Biolabs, Inc. (AIDX) is an innovative biotechnology firm committed to revolutionizing genomic research and diagnostics through its advanced laboratory services. With a keen focus on enhancing the accuracy and efficiency of genetic testing for clinical and research purposes, the company is poised to be a leader in the molecular diagnostics landscape. By leveraging state-of-the-art technologies, 20/20 Biolabs is strategically positioned to capitalize on the growing demand for personalized medicine and genomic data. Its strong market presence and forward-thinking initiatives underscore a compelling growth outlook within the rapidly evolving biotechnology sector.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?